Your browser doesn't support javascript.
loading
Immune checkpoint inhibitor-associated sarcoidosis: A usually benign disease that does not require immunotherapy discontinuation.
Chanson, Noémie; Ramos-Casals, Manuel; Pundole, Xerxes; Suijkerbuijk, Karijn; José de Barros E Silva, Milton; Lidar, Merav; Benesova, Karolina; Leipe, Jan; Acar-Denizli, Nihan; Pradère, Pauline; Michot, Jean-Marie; Voisin, Anne-Laure; Suárez-Almazor, Maria E; Radstake, Timothy R D; Fernandes Moça Trevisani, Virginia; Schulze-Koops, Hendrik; Melin, Audrey; Robert, Caroline; Mariette, Xavier; Baughman, Robert P; Lambotte, Olivier.
Afiliação
  • Chanson N; AP-HP.Université Paris-Saclay, Hôpital Bicêtre, Department of Internal Medicine and Clinical Immunology, Le Kremlin Bicêtre, France; Université Paris-Saclay; INSERM; CEA, Centre Immunology of Viral Infections and Autoimmune Diseases, IDMIT Department, IBFJ, Le Kremlin-Bicêtre, France.
  • Ramos-Casals M; Department of Autoimmune Diseases, ICMiD, Hospital Clínic, Barcelona, Spain; Laboratory of Autoimmune Diseases Josep Font, IDIBAPS-CELLEX, Barcelona, Spain; Department of Medicine, University of Barcelona, Barcelona, Spain. Electronic address: mramos@clinic.ub.es.
  • Pundole X; Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Suijkerbuijk K; Department of Medical Oncology, UMC Utrecht Cancer Center, Utrecht, the Netherlands.
  • José de Barros E Silva M; AC Camargo Cancer Center, Brazil.
  • Lidar M; Rheumatology Unit, Sheba Medical Center, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Benesova K; Department of Internal Medicin and Rheumatology, Universitätsklinikum Heidelberg, Germany.
  • Leipe J; Division of Rheumatology, Department of Medicine V, University Hospital Mannheim, Medical Faculty Mannheim of the University Heidelberg, German.
  • Acar-Denizli N; Department of Statistics, Faculty of Science and Letters, Mimar Sinan Fine Arts University, Istanbul, Turkey.
  • Pradère P; Department of Thoracic Surgery, Hôpital Marie-Lannelongue, Le Plessis-Robinson, France.
  • Michot JM; Département D'Innovation Thérapeutique et D'Essais Précoces, Institut Gustave Roussy, Université Paris-Saclay, Villejuif, F-94805, France.
  • Voisin AL; Unité Fonctionnelle de Pharmacovigilance, Institut Gustave Roussy, Université Paris-Saclay, Villejuif, F-94805, France.
  • Suárez-Almazor ME; Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Radstake TRD; Department of Medical Oncology, UMC Utrecht Cancer Center, Utrecht, the Netherlands.
  • Fernandes Moça Trevisani V; Federal University of São Paulo, Sao Paulo, Brazil.
  • Schulze-Koops H; Department of Internal Medicin and Rheumatology, Universitätsklinikum Heidelberg, Germany.
  • Melin A; Department of Dermatology, Institut Gustave Roussy, Université Paris-Saclay, Villejuif, F-94805, France.
  • Robert C; Department of Dermatology, Institut Gustave Roussy, Université Paris-Saclay, Villejuif, F-94805, France.
  • Mariette X; Université Paris-Saclay; INSERM; CEA, Centre Immunology of Viral Infections and Autoimmune Diseases, IDMIT Department, IBFJ, Le Kremlin-Bicêtre, France; AP-HP.Université Paris-Saclay, Department of Rheumatology, Hôpital Bicêtre, Le Kremlin Bicêtre, France.
  • Baughman RP; Department of Medicine, University of Cincinnati Medical Center, Cincinnati, OH, USA.
  • Lambotte O; AP-HP.Université Paris-Saclay, Hôpital Bicêtre, Department of Internal Medicine and Clinical Immunology, Le Kremlin Bicêtre, France; Université Paris-Saclay; INSERM; CEA, Centre Immunology of Viral Infections and Autoimmune Diseases, IDMIT Department, IBFJ, Le Kremlin-Bicêtre, France. Electronic add
Eur J Cancer ; 158: 208-216, 2021 11.
Article em En | MEDLINE | ID: mdl-34452793
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Sarcoidose / Inibidores de Checkpoint Imunológico / Imunoterapia Tipo de estudo: Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Cancer Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Sarcoidose / Inibidores de Checkpoint Imunológico / Imunoterapia Tipo de estudo: Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Cancer Ano de publicação: 2021 Tipo de documento: Article